SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-002112
Filing Date
2020-06-29
Accepted
2020-06-29 14:52:35
Documents
66
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT canna_10q-033120.htm 10-Q 469357
2 CERTIFICATION canna_ex3101.htm EX-31.1 11211
3 CERTIFICATION canna_ex3102.htm EX-31.2 11250
4 CERTIFICATION canna_ex3200.htm EX-32 4651
  Complete submission text file 0001683168-20-002112.txt   3171279

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20200331.xml EX-101.INS 459770
6 XBRL SCHEMA FILE cpmd-20200331.xsd EX-101.SCH 36704
7 XBRL CALCULATION FILE cpmd-20200331_cal.xml EX-101.CAL 57630
8 XBRL DEFINITION FILE cpmd-20200331_def.xml EX-101.DEF 173609
9 XBRL LABEL FILE cpmd-20200331_lab.xml EX-101.LAB 268255
10 XBRL PRESENTATION FILE cpmd-20200331_pre.xml EX-101.PRE 242017
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 20996981
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences